Compassionate use of esketamine intranasal in patients with severe major depressive disorder resistant to the treatment.
Gutiérrez-Rojas L, Vendrell-Serres J, Ramos-Quiroga JA, Etxeandia-Pradera JI, Aguilar E, De Santiago-Díaz AI, Hernández-Huerta D, Tordera V, Vázquez-Ventoso C, Bolívar M, Abril A, Catalán-Barragán R, García-Jiménez J.
Gutiérrez-Rojas L, et al. Among authors: garcia jimenez j.
J Psychopharmacol. 2024 Aug 7:2698811241267837. doi: 10.1177/02698811241267837. Online ahead of print.
J Psychopharmacol. 2024.
PMID: 39113255